疾病自然疗法
分享&收藏慢性阻塞性肺病(COPD)自然疗法
慢性阻塞性肺病 (COPD) 是一种永久性的肺部病变,最常见的原因是吸烟。刚起病的时候,患者只有喘鸣咳嗽,然后缓慢进展,出现气短,这甚至在穿衣、吃饭等轻体力活动时都会出现。COPD包括肺气肿和慢性支气管炎。
肺气肿是因为小肺泡被破坏,同时肺泡周围的支架结构变薄弱。它会削弱患者吸入氧气和呼出二氧化碳的能力。
慢性支气管炎是由气道炎症引起的持续性排痰性咳嗽。它也会破坏人体交换气体的能力。偶尔,当细菌在肺部感染时则会引起症状的急性加重。

由于吸烟是导致肺气肿和慢性支气管炎的重要原因,因此任何一个COPD患者都应该戒烟。戒烟虽然不会逆转病情,但能减缓COPD的恶化。另外,空气中的化学烟尘等刺激物会加重症状,也应尽量避免。COPD的常规治疗包括使用有减少肌肉痉挛作用的支气管扩张剂 (如异丙托铵、沙丁胺醇等),和使用糖皮质激素来控制气道炎症。急性加重时可加用抗生素。严重的COPD可能需要持续氧疗。
营养不良在COPD患者中非常常见。研究提示,随着COPD的进展,患者所需的卡路里也随之增加。另外,由于营养不良反过来会恶化肺功能,使患者更容易感染,因此现在有很多研究者建议COPD患者应将补充营养作为治疗的一部分。
COPD的自然疗法有:
- N-乙酰半胱氨酸(NAC):它是一种从食用氨基酸 (半胱氨酸) 改变而来的一种特殊氨基酸。研究人员通过对18项NAC治疗COPD的双盲临床试验的综合性分析发现:每天服用400-1200mg NAC能减少严重支气管炎的急性发作。
- 左旋肉碱 (L-carnitine):有三项双盲研究的证据均支持:补充左旋肉碱能改善COPD患者的运动耐受性。研究人员推测这可能与它改善肺部及其他部位肌肉的性能有关。
- 精油单萜类 (Essential oil monoterpenes):联合精油疗法中的精油包含来自桉树的桉油精、柑橘的d-柠檬油精、松树的α-松油二环烯。该疗法已经被用来治疗多种呼吸道疾患。由于这些精油在分子结构上属于同一家族单萜类,因此该疗法就被称为精油单萜类疗法。一项双盲研究发现用精油单萜类疗法也有助于预防慢性支气管炎的急性发作。这可能和它能改善肺清除分泌物的能力有关。
- 紫锥花 (Echinacea)、野生靛蓝 (Wild indigo) 和白雪松 (White cedar) 提取物混合制剂:该混合制剂显示出对治疗各种各样的呼吸道感染有一定的作用。一项双盲研究评估了它对慢性支气管急性加重的疗效。所有的参与者均接受常规的抗炎治疗。结果显示:同时接受这种混合制剂治疗的患者要比安慰剂组更快地改善肺功能。
- 低碳水化合物膳食 (Low-carbohydrate diet):来自几项研究的证据提示:高碳水化合物膳食会恶化COPD患者的肺功能和运动机能,而低碳水化合物膳食则有改善作用。这是因为碳水化合物会引起人体产生更多的二氧化碳,从而加重COPD患者排出二氧化碳的困难。

参考文献
- Fiaccadori E, Del Canale S, Coffrini E, et al. Hypercapnic-hypoxemic chronic obstructive pulmonary disease (COPD): influence of severity of COPD on nutritional status. Am J Clin Nutr. 1988;48:680-685.
- Openbrier DR, Irwin MM, Rogers RM, et al. Nutritional status and lung function in patients with emphysema and chronic bronchitis. Chest. 1983;83:17-22.
- Keim NL, Luby MH, Braun SR, et al. Dietary evaluation of outpatients with chronic obstructive pulmonary disease. J Am Diet Assoc. 1986;86:902-906.
- Keim NL, Luby MH, Braun SR, et al. Dietary evaluation of outpatients with chronic obstructive pulmonary disease. J Am Diet Assoc. 1986;86:902-906.
- Pingleton SK, Harmon GS. Nutritional management in acute respiratory failure. JAMA. 1987;257:3094-3099.
- Grandjean EM, Berthet P, Ruffmann R, et al. Efficacy of oral long-term N-acetylcysteine in chronic bronchopulmonary disease: a meta-analysis of published double-blind, placebo-controlled clinical trials. Clin Ther. 2000;22:209-221.
- Hansen NCG, Skriver A, Brorsen-Riis L, et al. Orally administered N-acetylcysteine may improve general well-being in patients with mild chronic bronchitis. Respir Med. 1994;88:531-535.
- Grassi C, Casali L, Rossi A, et al. A comparison between different methods for detecting bronchial hyperreactivity. Bronchial hyperreactivity: methods of study. Eur J Respir Dis Suppl. 1980;106:19-27.
- Grassi C, Morandini GC. A controlled trial of intermittent oral acetylcysteine in the long-term treatment of chronic bronchitis. Eur J Clin Pharmacol. 1976;9:393-396.
- Riise GC, Larsson S, Larsson P, et al. The intrabronchial microbial flora in chronic bronchitis patients: a target for N-acetylcysteine therapy? Eur Respir J. 1994;7:94-101.
- Rasmussen JB, Glennow C. Reduction in days of illness after long-term treatment with N-acetylcysteine controlled-release tablets in patients with chronic bronchitis. Eur Respir J. 1988;1:351-355.
- Parr GD, Huitson A. Oral fabrol (oral N-acetylcysteine) in chronic bronchitis. Br J Dis Chest. 1987;81:341-348.
- Boman G, Bcker U, Larsson S, et al. Oral acetylcysteine reduces exacerbation rate in chronic bronchitis: report of a trial organized by the Swedish Society for Pulmonary Diseases. Eur J Respir Dis. 1983;64:405-415.
- Verstraeten JM. Mucolytic treatment in chronic obstructive pulmonary disease. Double-blind comparaive clinical trial with N-acetylcysteine, bromhexine and placebo. Acta Tuberc Pneumol Belg. 1979;70:71-80.
- Dal Negro R, Pomari G, Zoccatelli O, et al. L-carnitine and rehabilitative respiratory physiokinesitherapy: metabolic and ventilatory response in chronic respiratory insufficiency. Int J Clin Pharmacol. 1986;24:453-456.
- Dal Negro R, Turco P, Pomari C, et al. Effects of L-carnitine on physical performance in chronic respiratory insufficiency. Int J Clin Pharmacol. 1988;26:269-272.
- Dal Negro R, Zoccatelli D, Pomari C, et al. L-carnitine and physiokinesiotherapy in chronic respiratory insufficiency. Preliminary results. Clin Trials J. 1985;22:353-360.
- Efthimiou J, Mounsey PJ, Benson DN, et al. Effect of carbohydrate rich versus fat rich loads of gas exchange and walking performance in patients with chronic obstructive lung disease. Thorax. 1992;47:451-456.
- Angelillo VA, Bedi S, Durfee D, et al. Effects of low and high carbohydrate feedings in ambulatory patients with chronic obstructive pulmonary disease and chronic hypercapnia. Ann Intern Med. 1985;103:883-885.
- Frankfort JD, Fischer CE, Stansbury DW, et al. Effects of high- and low-carbohydrate meals on maximum exercise performance in chronic airflow obstruction. Chest. 1991;100:792-795.
- Meister R, Wittig T, Beuscher N, et al. Efficacy and tolerability of Myrtol standardized in long-term treatment of chronic bronchitis. A double-blind, placebo-controlled study. Study Group Investigators. Arzneimittelforschung. 1999;49:351-358.


